Chemical Biology & Drug Design,
Journal Year:
2021,
Volume and Issue:
100(6), P. 843 - 869
Published: Sept. 30, 2021
Abstract
Over
the
past
few
decades,
dynamic
progress
in
synthesis
and
screening
of
heterocyclic
compounds
against
various
targets
has
made
a
significant
contribution
field
medicinal
chemistry.
Among
wide
array
compounds,
triazole
moiety
attracted
attention
researchers
owing
to
its
vast
therapeutic
potential
easy
preparation
via
copper
ruthenium‐catalyzed
azide‐alkyne
cycloaddition
reactions.
Triazole
skeletons
are
found
as
major
structural
components
different
class
drugs
possessing
diverse
pharmacological
profiles
including
anti‐cancer,
anti‐bacterial,
anti‐fungal,
anti‐viral,
anti‐oxidant,
anti‐inflammatory,
anti‐diabetic,
anti‐tubercular,
anti‐depressant
among
others.
Furthermore,
years,
significantly
large
number
hybrids
were
synthesized
with
moieties
order
gain
added
advantage
improved
profile,
overcoming
multiple
drug
resistance
reduced
toxicity
from
molecular
hybridization.
these
hybrids,
many
available
commercially
used
for
treating
infections/disorders
like
tazobactam
cefatrizine
potent
anti‐bacterial
agents
while
isavuconazole
ravuconazole
anti‐fungal
activities
name
few.
In
this
review,
we
will
summarize
biological
1,2,3‐triazole
copious
oxygen‐containing
heterocycles
lead
This
review
be
very
helpful
working
modeling,
design
development,
Frontiers in Pharmacology,
Journal Year:
2021,
Volume and Issue:
12
Published: Nov. 3, 2021
Nowadays,
nitrogenous
heterocyclic
molecules
have
attracted
a
great
deal
of
interest
among
medicinal
chemists.
Among
these
potential
drugs,
benzimidazole
scaffolds
are
considerably
prevalent.
Due
to
their
isostructural
pharmacophore
naturally
occurring
active
biomolecules,
derivatives
significant
importance
as
chemotherapeutic
agents
in
diverse
clinical
conditions.
Researchers
synthesized
plenty
the
last
decades,
amidst
large
share
compounds
exerted
excellent
bioactivity
against
many
ailments
with
outstanding
bioavailability,
safety,
and
stability
profiles.
In
this
comprehensive
review,
we
summarized
reported
recent
literature
(2012–2021)
available
structure-activity
relationship.
Compounds
bearing
nucleus
possess
broad-spectrum
pharmacological
properties
ranging
from
common
antibacterial
effects
world’s
most
virulent
diseases.
Several
promising
therapeutic
candidates
undergoing
human
trials,
some
going
be
approved
for
use.
However,
notable
challenges,
such
drug
resistance,
costly
tedious
synthetic
methods,
little
structural
information
receptors,
lack
advanced
software,
so
on,
still
viable
overcome
further
research.
Pharmaceuticals,
Journal Year:
2021,
Volume and Issue:
14(7), P. 663 - 663
Published: July 11, 2021
A
significant
number
of
the
anti-inflammatory
drugs
currently
in
use
are
becoming
obsolete.
These
exceptionally
hazardous
for
long-term
because
their
possible
unfavourable
impacts.
Subsequently,
ebb-and-flow
decade,
analysts
and
researchers
engaged
developing
new
drugs,
many
such
agents
later
phases
clinical
trials.
Molecules
with
heterocyclic
nuclei
similar
to
various
natural
antecedents,
thus
acquiring
immense
consideration
from
scientific
experts
researchers.
The
arguably
most
adaptable
cores
benzimidazoles
containing
nitrogen
a
bicyclic
scaffold.
Numerous
benzimidazole
broadly
used
treatment
numerous
diseases,
showing
promising
therapeutic
potential.
Benzimidazole
derivatives
exert
effects
mainly
by
interacting
transient
receptor
potential
vanilloid-1,
cannabinoid
receptors,
bradykinin
specific
cytokines,
5-lipoxygenase
activating
protein
cyclooxygenase.
Literature
on
structure–activity
relationship
(SAR)
investigations
highlight
that
substituent’s
tendency
position
ring
significantly
contribute
activity.
Reported
SAR
analyses
indicate
substitution
at
N1,
C2,
C5
C6
positions
scaffold
greatly
influence
For
example,
substituted
anacardic
acid
C2
inhibits
COX-2,
5-carboxamide
or
sulfamoyl
sulfonyl
antagonises
receptor,
whereas
diarylamine
C3
carboxamide
result
antagonism
receptor.
In
this
review,
we
examine
insights
regarding
SARs
compounds,
which
will
be
helpful
designing
target
inflammation-promoting
enzymes.
Pharmaceuticals,
Journal Year:
2021,
Volume and Issue:
14(7), P. 692 - 692
Published: July 19, 2021
Rheumatoid
arthritis,
arthrosis
and
gout,
among
other
chronic
inflammatory
diseases
are
public
health
problems
represent
major
therapeutic
challenges.
Non-steroidal
anti-inflammatory
drugs
(NSAIDs)
the
most
prescribed
clinical
treatments,
despite
their
severe
side
effects
exclusive
action
in
improving
symptoms,
without
effectively
promoting
cure.
However,
recent
advances
fields
of
pharmacology,
medicinal
chemistry,
chemoinformatics
have
provided
valuable
information
opportunities
for
development
new
drug
candidates.
For
design
discovery,
thiophene
derivatives
privileged
structures.
Thiophene-based
compounds,
like
commercial
Tinoridine
Tiaprofenic
acid,
known
properties.
The
present
review
provides
an
update
on
role
thiophene-based
inflammation.
Studies
mechanisms
action,
interactions
with
receptors
(especially
against
cyclooxygenase
(COX)
lipoxygenase
(LOX)),
structure-activity
relationships
also
presented
discussed.
results
demonstrate
importance
compounds
as
structures
discovery
novel
agents.
studies
reveal
important
structural
characteristics.
presence
carboxylic
acids,
esters,
amines,
amides,
well
methyl
methoxy
groups,
has
been
frequently
described,
highlights
these
groups
activity
biological
target
recognition,
especially
inhibition
COX
LOX
enzymes.
Antibiotics,
Journal Year:
2021,
Volume and Issue:
10(8), P. 1002 - 1002
Published: Aug. 19, 2021
The
synthesis
of
new
compounds
with
antimicrobial
and
antiviral
properties
is
a
central
objective
today
in
the
context
COVID-19
pandemic.
Benzimidazole
pyrazole
have
remarkable
biological
properties,
such
as
antimicrobial,
antiviral,
antitumor,
analgesic,
anti-inflammatory,
anti-Alzheimer’s,
antiulcer,
antidiabetic.
Moreover,
recent
literature
mentions
syntheses
some
benzimidazole–pyrazole
hybrids,
well
other
thereof.
In
this
review,
we
aim
to
review
methods
these
activities
compounds,
their
correlation
various
groups
present
on
molecule,
pharmaceutical
properties.
Horticulturae,
Journal Year:
2022,
Volume and Issue:
8(4), P. 301 - 301
Published: March 31, 2022
The
application
of
microbial
products
as
natural
biocontrol
agents
for
inducing
systemic
resistance
against
plant
viral
infections
represents
a
promising
strategy
sustainable
and
eco-friendly
agricultural
applications.
Under
greenhouse
conditions,
the
efficacy
culture
filtrate
Bacillus
subtilis
strain
HA1
(Acc#
OM286889)
protecting
tomato
plants
from
Tobacco
mosaic
virus
(TMV)
infection
was
assessed.
results
showed
that
dual
foliar
this
(HA1-CF)
24
h
before
after
TMV
inoculation
most
effective
treatment
enhancing
development,
with
substantial
improvements
in
shoot
root
parameters.
Furthermore,
compared
to
non-treated
plants,
HA1-CF-treated
had
significant
increase
total
phenolic
flavonoid
contents
up
27%
50%,
respectively.
In
addition,
considerable
activities
reactive
oxygen
species
scavenging
enzymes
(PPO,
SOD,
POX)
decrease
non-enzymatic
oxidative
stress
markers
(H2O2
MDA)
were
reported.
comparison
untreated
control
all
reduction
accumulation
systemically
infected
leaves,
91%
at
15
dpi.
qRT-PCR
confirmed
HA1-CF
stimulated
transcription
several
defense-related
genes
(PR-1,
PAL,
CHS,
HQT),
pointing
their
potential
role
induced
TMV.
GC–MS
analysis
phenol,
2,4-bis
(1,1-dimethylethyl)-,
Pyrrolo
[1,2-a]
pyrazine-1,4-dione,
hexahydro-3-(2-methylpropyl)-
eicosane
are
primary
ingredient
compounds
ethyl
acetate
extract,
suggesting
these
molecules
take
part
stimulating
plants.
Our
imply
is
inducer
infections,
growth
promoter,
source
bioactive
disease
management.